News
NRXBF
0.510
+6.09%
0.029
NurExone Announces Closing of C$1,066,078 Private Placement
Barchart · 22h ago
Weekly Report: what happened at NRXBF last week (0810-0814)?
Weekly Report · 4d ago
NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model
Barchart · 08/14 07:59
Weekly Report: what happened at NRXBF last week (0803-0807)?
Weekly Report · 08/10 10:23
Weekly Report: what happened at NRXBF last week (0727-0731)?
Weekly Report · 08/03 10:22
Weekly Report: what happened at NRXBF last week (0720-0724)?
Weekly Report · 07/27 10:27
Weekly Report: what happened at NRXBF last week (0713-0717)?
Weekly Report · 07/20 10:23
Weekly Report: what happened at NRXBF last week (0706-0710)?
Weekly Report · 07/13 10:25
Weekly Report: what happened at NRXBF last week (0629-0703)?
Weekly Report · 07/06 10:29
NurExone Announces Closing of Non-Brokered Private Placement
Barchart · 06/30 07:31
Weekly Report: what happened at NRXBF last week (0622-0626)?
Weekly Report · 06/29 10:24
EXCLUSIVE: France Based NurExone Targets Mexico Wellness Market With Exosome Supply Agreement
Benzinga · 06/24 20:31
EXCLUSIVE: NurExone's Wholly-Owned Subsidiary Enters Into Binding MOU For Naïve Exosome Distribution in Mexico
Benzinga · 06/24 20:30
Weekly Report: what happened at NRXBF last week (0615-0619)?
Weekly Report · 06/22 10:34
Weekly Report: what happened at NRXBF last week (0608-0612)?
Weekly Report · 06/15 10:34
Weekly Report: what happened at NRXBF last week (0601-0605)?
Weekly Report · 06/08 10:29
Weekly Report: what happened at NRXBF last week (0525-0529)?
Weekly Report · 06/01 10:35
NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
Barchart · 06/01 07:02
Weekly Report: what happened at NRXBF last week (0518-0522)?
Weekly Report · 05/25 10:39
Weekly Report: what happened at NRXBF last week (0511-0515)?
Weekly Report · 05/18 10:38
More
Webull provides a variety of real-time NRXBF stock news. You can receive the latest news about Nurexone Biologic Inc through multiple platforms. This information may help you make smarter investment decisions.
About NRXBF
Nurexone Biologic Inc is an Israel-based company engaged primarily in the pharmaceutical sector. The Company is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s flagship product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and sIRNA sequence as the active pharmaceutical ingredient. Its ExoTherapy is a platform for developing exosome-based therapies. The NurExone platform technology is expected to offer solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. The Company focuses on research and development of pharmaceutical technologies.